Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 419

1.

Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage.

Bay-Jensen AC, Andersen TL, Charni-Ben Tabassi N, Kristensen PW, Kjaersgaard-Andersen P, Sandell L, Garnero P, Delaissé JM.

Osteoarthritis Cartilage. 2008 May;16(5):615-23. Epub 2007 Oct 22.

2.

Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.

Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD.

Arthritis Rheum. 2002 Oct;46(10):2613-24.

3.

The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation.

Charni-Ben Tabassi N, Desmarais S, Bay-Jensen AC, Delaissé JM, Percival MD, Garnero P.

Osteoarthritis Cartilage. 2008 Oct;16(10):1183-91. doi: 10.1016/j.joca.2008.02.008. Epub 2008 Apr 9.

4.

The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover.

Bay-Jensen AC, Tabassi NC, Sondergaard LV, Andersen TL, Dagnaes-Hansen F, Garnero P, Kassem M, Delaissé JM.

Arthritis Res Ther. 2009;11(1):R9.

6.

A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.

Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P.

Rheumatology (Oxford). 2007 Jun;46(6):938-43. Epub 2007 Mar 26.

8.
9.

Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.

Rousseau JC, Chevrel G, Schott AM, Garnero P.

Bone. 2010 Apr;46(4):897-900. doi: 10.1016/j.bone.2009.12.003. Epub 2009 Dec 11.

PMID:
20005316
12.

Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.

Christgau S, Henrotin Y, Tankó LB, Rovati LC, Collette J, Bruyere O, Deroisy R, Reginster JY.

Clin Exp Rheumatol. 2004 Jan-Feb;22(1):36-42.

PMID:
15005002
13.

Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey.

Tanishi N, Yamagiwa H, Hayami T, Mera H, Koga Y, Omori G, Endo N.

J Bone Miner Metab. 2009;27(5):605-12. doi: 10.1007/s00774-009-0077-3. Epub 2009 Apr 21.

PMID:
19381754
15.
16.

Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees.

Weng LH, Wang CJ, Ko JY, Sun YC, Wang FS.

Arthritis Rheum. 2010 May;62(5):1393-402. doi: 10.1002/art.27357.

17.

Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.

Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, Minoura K, Hirayama Y, Ohkubo Y, Mutoh S.

J Rheumatol. 2004 Jun;31(6):1174-9.

PMID:
15170932
19.
20.

Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.

Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C.

Osteoarthritis Cartilage. 2009 Mar;17(3):384-9. doi: 10.1016/j.joca.2008.07.009. Epub 2008 Sep 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk